| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
disease | 0.700 | None | 0.982 | 4 | 0 | 2000 | 2020 | ||||||||
|
regulator of calcineurin 1 | 0.572 | 0.808 | 1.7E-02 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2003 | 2019 | ||||||||
|
cathepsin D | 0.478 | 0.846 | 9.2E-04 |
|
disease | 0.100 | None | 0.887 | 3 | 0 | 1991 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.919 | 3 | 0 | 2005 | 2020 | ||||||||
|
24-dehydrocholesterol reductase | 0.498 | 0.769 | 3.1E-02 |
|
disease | 0.400 | None | 0.958 | 3 | 0 | 2000 | 2019 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.100 | None | 0.923 | 3 | 0 | 1998 | 2020 | ||||||||
|
granulin precursor | 0.435 | 0.846 | 7.0E-02 |
|
disease | 0.200 | None | 0.970 | 3 | 0 | 2006 | 2019 | ||||||||
|
solute carrier family 6 member 3 | 0.453 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1997 | 2020 | ||||||||
|
insulin degrading enzyme | 0.604 | 0.577 | 6.6E-03 |
|
disease | 0.600 | None | 0.955 | 3 | 0 | 2000 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.100 | None | 0.947 | 3 | 0 | 1998 | 2019 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
disease | 0.400 | None | 0.920 | 3 | 0 | 1995 | 2020 | ||||||||
|
transcription factor CP2 | 0.650 | 0.385 | 3.6E-06 |
|
disease | 0.080 | None | 1.000 | 3 | 0 | 2000 | 2018 | ||||||||
|
serpin family A member 3 | 0.486 | 0.846 | 8.8E-14 |
|
disease | 0.100 | None | 0.926 | 3 | 0 | 1988 | 2019 | ||||||||
|
prion protein | 0.445 | 0.923 | 6.3E-04 |
|
disease | 0.400 | None | 0.902 | 3 | 0 | 1986 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2005 | 2019 | ||||||||
|
cytochrome P450 family 46 subfamily A member 1 | 0.659 | 0.500 | 0.99 |
|
disease | 0.400 | None | 0.953 | 3 | 0 | 2000 | 2019 | ||||||||
|
nerve growth factor receptor | 0.477 | 0.846 | 9.8E-02 |
|
disease | 0.300 | None | 0.957 | 3 | 0 | 1989 | 2019 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
disease | 0.300 | None | 0.979 | 3 | 0 | 2001 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1999 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.100 | None | 0.857 | 3 | 0 | 1999 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.895 | 3 | 0 | 1993 | 2019 | ||||||||
|
cyclin dependent kinase 5 regulatory subunit 1 | 0.529 | 0.808 | 0.91 |
|
disease | 0.100 | None | 0.960 | 3 | 0 | 2001 | 2019 | ||||||||
|
ceruloplasmin | 0.466 | 0.846 | 4.2E-10 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2007 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.300 | None | 0.960 | 3 | 0 | 1997 | 2019 |